Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling

European Journal of Cancer

Volumn 48, Issue 6, 2012, Pages 837-844

  Ohri, Nitin ^a   Dicker, Adam P ^a   Trabulsi, Edouard J ^a   Showalter, Timothy N ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Dose; Late toxicity; Prostate cancer; PSA; Salvage radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; CANCER RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MALE; META ANALYSIS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; RADIATION DOSE; RADIOBIOLOGY; REVIEW; SALVAGE THERAPY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE;

DISEASE-FREE SURVIVAL; HUMANS; MALE; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; SALVAGE THERAPY;

EID: 82455221660     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.08.013     Document Type: Article

References (55)

1. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597 (Pubitemid 29211767)
2. S.A. Boorjian, R.J. Karnes, and P.L. Crispen Radiation therapy after radical prostatectomy: impact on metastasis and survival J Urol 182 2009 2708 2714
3. C.R. King Adjuvant Radiotherapy After Prostatectomy: Does Waiting for a Detectable Prostate-Specific Antigen Level Make Sense? Int J Radiat Oncol Biol Phys 80 2011 1 3
4. B.A. Jereczek-Fossa, D. Zerini, and C. Fodor Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy Int J Radiat Oncol Biol Phys 78 2010 26 34
5. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041 (Pubitemid 46972788)
6. C.R. King, and D.S. Kapp Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71 2008 346 350
7. C.R. King, and M.T. Spiotto Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 2008 23 27
8. J.R. Bernard Jr., S.J. Buskirk, and M.G. Heckman Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis Int J Radiat Oncol Biol Phys 76 2010 735 740
9. N. Tomita, T. Kodaira, and K. Furutani Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy J Cancer Res Clin Oncol 135 2009 1561 1567
10. R.K. Valicenti, L.G. Gomella, and M. Ismail Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose Urology 52 1998 1034 1040 (Pubitemid 28533373)
11. Cozzarini C, Fiorino C, Da Pozzo LF, et al. Clinical Factors Predicting Late Severe Urinary Toxicity After Postoperative Radiotherapy for Prostate Carcinoma. Int J Radiat Oncol Biol Phys 2010, in press.
12. C.T. Lee, and J.E. Oesterling Using prostate-specific antigen to eliminate the staging radionuclide bone scan Urol Clin North Am 24 1997 389 394 (Pubitemid 27169263)
13. R.G. Cremers, E.N. van Lin, and W.L. Gerrits Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy Radiother Oncol 97 2010 467 473
14. T.J. Kruser, D.F. Jarrard, and A.K. Graf Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence Cancer 117 2011 2629 2636
15. G.W. Wong, K.L. Palazzi-Churas, and D.F. Jarrard Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy Int J Radiat Oncol Biol Phys 70 2008 449 455
16. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694 (Pubitemid 19194494)
17. H. Suit, S. Skates, and A. Taghian Clinical implications of heterogeneity of tumor response to radiation therapy Radiother Oncol 25 1992 251 260 (Pubitemid 23000767)
18. A. Niemierko, and M. Goitein Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture Radiother Oncol 20 1991 166 176
19. M.S. Anscher, R. Clough, and R. Dodge Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years Int J Radiat Oncol Biol Phys 48 2000 369 375
20. A.K. Chawla, H.K. Thakral, and A.L. Zietman Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors Urology 59 2002 726 731 (Pubitemid 34461985)
21. N. Taylor, J.F. Kelly, and D.A. Kuban Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 56 2003 755 763 (Pubitemid 36677369)
22. T. Wiegel, G. Lohm, and D. Bottke Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome - results of a retrospective study Int J Radiat Oncol Biol Phys 73 2009 1009 1016
23. R. Choo, G. Hruby, and J. Hong Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not? Int J Radiat Oncol Biol Phys 52 2002 674 680 (Pubitemid 34158729)
24. M.S. Katz, M.J. Zelefsky, and E.S. Venkatraman Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer J Clin Oncol 21 2003 483 489 (Pubitemid 46606478)
25. J. Maier, J. Forman, and S. Tekyi-Mensah Salvage radiation for a rising PSA following radical prostatectomy Urol Oncol 22 2004 50 56 (Pubitemid 38542714)
26. O.K. MacDonald, S.E. Schild, and S. Vora Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology 64 2004 760 764 (Pubitemid 39446058)
27. T.M. Pisansky, T.F. Kozelsky, and R.P. Myers Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer J Urol 163 2000 845 850 (Pubitemid 30091629)
28. L. Quero, P. Mongiat-Artus, and V. Ravery Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience BMC Cancer 8 2008 26
29. I.M. Thompson Jr., C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335 (Pubitemid 44749360)
30. E.J. Trabulsi, R.K. Valicenti, and A.L. Hanlon A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer Urology 72 2008 1298 1302 [discussion 1302-1294]
31. J.P. Brooks, P.S. Albert, and R.B. Wilder Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors J Urol 174 2005 2204 2208 [discussion 2208] (Pubitemid 41611774)
32. D.M. Moreira, J. Jayachandran, and J.C. Presti Jr. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database BJU Int 104 2009 1452 1456
33. J.D. Cox, M.J. Gallagher, and E.H. Hammond Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation, for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology, Oncology Consensus Panel J Clin Oncol 17 1999 1155
34. J.F. Pazona, M. Han, and S.A. Hawkins Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates J Urol 174 2005 1282 1286 (Pubitemid 41318704)
35. S.J. Buskirk, T.M. Pisansky, and S.E. Schild Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system J Urol 176 2006 985 990 (Pubitemid 44160708)
36. J.F. Ward, H. Zincke, and E.J. Bergstralh Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy J Urol 172 2004 2244 2248 (Pubitemid 39507500)
37. O.K. Macdonald, A.V. D'Amico, and N. Sadetsky Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database Urol Oncol 26 2008 271 275 (Pubitemid 351608581)
38. A.J. Stephenson, M.W. Kattan, and J.A. Eastham Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition J Clin Oncol 24 2006 3973 3978 (Pubitemid 46630746)
39. C.L. Amling, E.J. Bergstralh, and M.L. Blute Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 165 2001 1146 1151 (Pubitemid 32210224)
40. H.I. Scher, M. Eisenberger, and A.V. D'Amico Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group J Clin Oncol 22 2004 537 556 (Pubitemid 41079783)
41. M.S. Cookson, G. Aus, and A.L. Burnett Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes J Urol 177 2007 540 545 (Pubitemid 46054056)
42. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80 (Pubitemid 350166735)
43. L. Boccon-Gibod, W.B. Djavan, and P. Hammerer Management of prostate-specific antigen relapse in prostate cancer: a European Consensus Int J Clin Pract 58 2004 382 390 (Pubitemid 38714445)
44. L.R. Witherspoon, and T. Lapeyrolerie Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy J Urol 157 1997 1322 1328 (Pubitemid 27130807)
45. E.J. Vassilikos, H. Yu, and J. Trachtenberg Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up Clin Biochem 33 2000 115 123 (Pubitemid 30212819)
46. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578 (Pubitemid 41140332)
47. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
48. G. De Meerleer, V. Fonteyne, and S. Meersschout Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy Radiother Oncol 89 2008 205 213
49. S.K. Nath, A.P. Sandhu, and B.S. Rose Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 78 2010 435 441
50. T.N. Showalter, N. Ohri, and K.G. Teti Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy Int J Radiat Oncol Biol Phys 2011
51. D. Neuhof Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy Int J Radiat Oncol Biol Phys 67 2007 1411 1417 (Pubitemid 46467172)
52. M. Pearse Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy Int J Radiat Oncol Biol Phys 72 2008 792 798
53. J.L. Peterson Late toxicity after postprostatectomy salvage radiation therapy Radiother Oncol 93 2009 203 206
54. Z. Symon Radiation rescue for biochemical failure after surgery for prostate cancer: predictive parameters and an assessment of contemporary predictive models Am J Clin Oncol 29 2006 446 450 (Pubitemid 44536024)
55. C. Tsien Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy Urology 62 2003 93 98 (Pubitemid 36802079)